Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum

Parasitology International

Volumn 48, Issue 2, 1999, Pages 169-177

  McManus, D P ^a,b   Ross, A G P ^a   Sleigh, A C ^a   Williams, G M ^a   Yang, W ^a   Li, Y S ^a,c   Li, Y ^c   Acosta, L ^d   Waine, G J ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^d RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

Author keywords

Cytokines; Human immune responses; IL 10; Interleukin 10; Recombinant antigens; Schistosoma japonicum; Schistosomiasis japonica

Indexed keywords

INTERLEUKIN 10; PARASITE ANTIGEN;

ARTICLE; CHINA; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

JAPONICA; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA;

EID: 0032868110     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(99)00015-X     Document Type: Article

References (41)

1. Butterworth A. Immunity in human schistosomiasis. Acta Trop Suppl. 12:1987;31-40.
2. Wilkins H.A., Blumenthal U.J., Hagan P. et al. Resistance to reinfection after treatment of urinary schistosomiasis. Trans R Soc Trop Med Hyg. 81:1987;29-35.
3. Hagan P., Blumenthal U.J., Dunne D. et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 349:1991;243-245.
4. Dunne D.W., Butterworth A.E., Fulford A.J.C. et al. R.F. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol. 22:1992;1483-1494.
5. Rihet P., Demeure C.E., Bourgois A. et al. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol. 21:1991;2679-2686.
6. Sturrock R., Kimani R., Cottrell B. et al. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Tran R Soc Trop Med Hyg. 77:1983;363-371.
7. Hagan P., Wilkins H.A., Blumenthal U.J. et al. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7:1985;625-632.
8. Grogan J.L., Kremsner P.G., Deelder A.M., Yazdanbakhsh M. Antigen-specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Inf Dis. 177:1998;1433-1437.
9. Bergquist R., Colley D.G. Schistosomiasis vaccines: research to development. Parasitol Today. 14:1998;99-104.
10. Roberts M., Butterworth A.E., Kimani G. et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun. 61:1993;4984-4993.
11. Viana I.R.C., Sher A., Carvalho O.S. et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg. 88:1994;466-470.
12. Medhat A., Shehata M., Bucci K. et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Inf Dis. 178:1998;512-519.
13. Boros D.L., Whitfield J.R. Endogenous IL-10 regulates IFN-γ and IL-5 cytokine production and the granulomatous response in schistosomiasis mansoni-infected mice. Immunology. 94:1998;481-487.
14. Falcao P.L., Malaquias L.C.C., Martins-Filho O.A. et al. Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol. 20:1998;447-454.
15. Couissinier-Paris P., Dessein A.J. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol. 25:1995;2295-2302.
16. Ribeiro de Jesus A.M., Almeida R.P., Bacellar O. et al. Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis. Eur J Immunol. 23:1993;152-158.
17. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol. 26:1996;1365-1370.
18. Grogan J.L., Kremsner P.G., Deelder A., Yazdanbakhsh M. The effect of anti-IL-10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells. Parasite Immunol. 20:1998;345-349.
19. Waine G.J., McManus D.P. Schistosomiasis vaccine development-the current picture. BioEssays. 19:1997;435-443.
20. Pearce E.J., James S.L., Hieny S. et al. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a non-surface parasite antigen. Proc Natl Acad Sci USA. 85:1988;5678-5682.
21. Flanigan T., King C., Lett R. et al. Induction of resistance to Schistosoma mansoni infection by mice by purified parasite paramyosin. J Clin Invest. 83:1989;1010-1014.
22. Ramirez B.L., Kurtis J.D., Weist P.M. et al. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol. 18:1996;49-52.
23. Tendler M., Brito C.A., Vila M.M. et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci. 93:1996;269-273.
24. Grzych J.M., Grezel D., Xu C. et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol. 150:1993;527-535.
25. Dunne D.W., Grabowska A., Fulford A. et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worms and resistance to reinfection. Eur J Immunol. 22:1992;1483-1494.
26. Dessein A.J., Begley M., Demeure C. et al. Human resistance to schistosomiasis is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol. 140:1988;2727-2736.
27. El Ridi R., Farouk F., Sherif M. et al. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium. J Inf Dis. 177:1998;1364-1372.
28. Kalinna B.H., Becker M., McManus D.P. Engineering and expression of a full length cDNA encoding Schistosoma japonicum paramyosin. Acta Trop. 65:1997;111-115.
29. Becker M., Kalinna B.H., Waine G.J., McManus D.P. Gene cloning, overproduction and purification of a functionally active cytoplasmic fatty acid-binding protein (Sj-FABPc) from the human blood fluke, Schistosoma japonicum. Gene. 148:1994;321-325.
30. Waine G.J., Becker M., Scott J. et al. Purification of a recombinant Schistosoma japonicum antigen homologous to the 22-kDa membrane associated antigen of S. mansoni, a putative vaccine candidate against schistosomiasis. Gene. 142:1994;259-263.
31. Waine G.J., Becker M., Yang W. et al. Cloning, molecular characterisation, and functional activity of Schistosoma japonicum glyceraldehyde-3-phosphate dehydrogenase, a putative vaccine candidate for schistosomiasis. Infect Immun. 61:1993;4716-4723.
32. Scott JC. Molecular immunological studies on Schistosoma japonicum. PhD thesis. University of Queensland, 1998.
33. Ross A.G.P., Yuesheng L., Sleigh A.S. et al. Epidemiologic features of Schistosoma japonicum among fisherman and other occupational groups in the Dongting Lake Region (Hunan Province) of China. Am J Trop Med Hyg. 57:1997;302-308.
34. Waine G.J., Yang W., Ross A.G.P. et al. Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population. Clin Exp Immunol. 112:1998;69-73.
35. Ross A.G.P., Yuesheng L., Sleigh A.S. et al. Measuring exposure to S. japonicum in China. 1. Activity diaries to assess water contact and comparison to other measures. Acta Trop. 71:1998;213-228.
36. Yang Y., Waine G.J., Sculley D. et al. Cloning and partial nucleotide sequence of Schistosoma japonicum paramyosin: a potential vaccine candidate against schistosomiasis. Int J Parasitol. 22:1992;1187-1191.
37. Ross A.G.P., Sleigh A.C., Li Y.S., Gangtin T., Williams G.M., McManus D.P. Epidemiologic identification of Chinese individuals putatively susceptible or unsusceptible to Schistosoma japonicum: a prelude to immunogenetic study of human resistance to Asian schistosomiaisis. Ann Trop Med Parasitol. 92:1998;765-774.
38. Pearce E. The immunology of schistosomiasis. Boothroyd J.C., Komuniecki R. Molecular approaches to parasitology. 1995;497-510 Wiley-Liss, Inc.
39. Punnonen J., de Waal Malefyt R., van Vlasselar P., Gauchat J.F., De Vries J.E. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol. 151:1993;1280-1289.
40. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol. 157:1996;377-384.
41. Muraille E., Leo O. Revisiting the Th1/Th2 paradigm. Scand J Immunol. 47:1998;1-9.